Facephi Biometria, S.A.
EPA:ALPHI.PA
1.58 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| 0.193 | 0.193 | -2.348 | -2.348 | 1.088 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 0 | 0 | 0 | 0 | 0 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -0.193 | -0.193 | 2.348 | 2.348 | -1.088 |
| Operating Cash Flow
| 0 | 0 | 0 | 0 | 0 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0 | 0 | 0 | 0 | 0 |
| Cash At End Of Period
| 0 | 0 | 0 | 0 | 0 |